Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Cardiovascular disease biotech company Scribe (SCTX.US) sets IPO price at $13-15 per share, aiming to raise $100 millions

Cardiovascular disease biotech company Scribe (SCTX.US) sets IPO price at $13-15 per share, aiming to raise $100 millions

智通财经智通财经2026/07/21 07:31
Show original
Zhitong Finance APP has learned that Scribe Therapeutics, a biotechnology company dedicated to developing CRISPR gene therapies for high cholesterol and currently in Phase I clinical trials, announced its initial public offering (IPO) terms on Monday. The company plans to issue 7.2 million shares at a price range of $13 to $15 per share, raising $100 million. The company intends to list on the Nasdaq under the stock code "SCTX."
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like